Sicriptin Tablet contains Bromocriptine Mesylate, a dopamine D2 receptor agonist. Doctors use it to treat hyperprolactinemia, prolactinomas, acromegaly, and Parkinson’s disease. Patients also use it to manage type 2 diabetes and suppress lactation in specific cases. Serum Institute of India manufactures Sicriptin, which comes in 1.25 mg and 2.5 mg strengths. Learn more about Bromocriptine at Mayo Clinic, Drugs.com, FDA, WebMD, PubMed, Healthline, WHO, and MedlinePlus.

Key Benefits & Uses

Sicriptin lowers prolactin levels and relieves symptoms like galactorrhea and amenorrhea (MedlinePlus). It reduces growth hormone levels to help manage acromegaly (PubMed). It also improves motor function in Parkinson’s disease (PubMed) and enhances blood sugar control in type 2 diabetes (PubMed). Doctors sometimes prescribe it to suppress lactation (PubMed).

How to Use

Take Sicriptin exactly as your doctor prescribes. Start with a low dose and increase it gradually. Take the tablet with food to reduce stomach upset. Take it at the same time each day for consistent results. Detailed instructions are available at Drugs.com and MedlinePlus.

Important Safety Information

Do not take Sicriptin if you are allergic to bromocriptine or similar drugs. Pregnant or breastfeeding women should consult a doctor before using it because bromocriptine may suppress lactation (PubMed). Tell your doctor about all medicines you take, including antifungals, HIV protease inhibitors, and macrolide antibiotics, as they may interact with bromocriptine (MedlinePlus).

Common Side Effects

Patients may feel nauseous, vomit, or have stomach cramps (PubChem). They may also experience dizziness, headache, fatigue, or sleepiness (DailyMed). Some patients develop low blood pressure, especially after the first dose (PubMed). Rarely, patients report confusion or hallucinations (PubMed).

Why Choose Sicriptin Tablet

Sicriptin treats hyperprolactinemia, Parkinson’s disease, and acromegaly effectively. Serum Institute of India manufactures it. The tablet works for multiple conditions and offers an affordable alternative to other dopamine agonists.